Abiochem Biotechnology
PrivateLast Round
Strategic
Jul 24, 2025
Total Funding Raised
$124.2M
Company Overview
Abiochem Biotechnology operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Strategic round in July 2025.
Abiochem Biotechnology is a synthetic biology company that develops and manufactures chemical and biological products for the pharmaceutical, agricultural, and food industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Smart Manufacturing, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abiochem Biotechnology Comparables
Compare Abiochem Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bota Biosciences | 81% | |
| 上海依诺基科生物技术有限公司 | 77% | |
| Tidetron Bioworks | 77% |
For institutional investors. Book with your work email.
Abiochem Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 24, 2025 | ||||
| Series C | Apr 30, 2021 | ||||
| Series B | Nov 30, 2020 | ||||
| Series A | Apr 3, 2019 | ||||
| Angel | Jun 28, 2018 |
For institutional investors. Book with your work email.
Abiochem Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Temasek | Series C |
| 招银国际金融有限公司 | Series C |
| Addor Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2025
$63M raised in strategic round.
- Apr 30, 2021
$46.3M round led by Temasek
For institutional investors. Book with your work email.
Abiochem Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abiochem Biotechnology's valuation, stock price, and market status.
Is Abiochem Biotechnology a public or private company?
Abiochem Biotechnology is a private company.
What is the current stock price of Abiochem Biotechnology?
Abiochem Biotechnology is a private company, so its shares have no public market price. Caplight tracks Abiochem Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abiochem Biotechnology worth (valuation)?
Valuation information for Abiochem Biotechnology is not publicly available.
Can I buy Abiochem Biotechnology stock?
Abiochem Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abiochem Biotechnology's last funding round?
Abiochem Biotechnology's most recent funding round was Strategic on July 24, 2025.
Who are the main investors in Abiochem Biotechnology?
Key investors in Abiochem Biotechnology include Temasek.
Will Abiochem Biotechnology IPO soon?
No public IPO plans have been announced for Abiochem Biotechnology.
How can I track Abiochem Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Abiochem Biotechnology's shares on secondary markets.